| Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2 N Ashary, A Bhide, P Chakraborty, S Colaco, A Mishra, K Chhabria, ... Frontiers in cell and developmental biology 8, 783, 2020 | 129 | 2020 |
| A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells S Tripathi, P Chakraborty, H Levine, MK Jolly PLOS Computational Biology 16 (2), e1007619, 2020 | 98 | 2020 |
| Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum P Chakraborty, JT George, S Tripathi, H Levine, MK Jolly Frontiers in Bioengineering and Biotechnology 8, 220, 2020 | 77 | 2020 |
| Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT W Jia, S Tripathi, P Chakraborty, A Chedere, A Rangarajan, H Levine, ... Oncotarget 11 (27), 2611, 2020 | 28 | 2020 |
| Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum P Chakraborty, JT George, WA Woodward, H Levine, MK Jolly Translational oncology 14 (4), 101026, 2021 | 20 | 2021 |
| Dynamic plasticity within the EMT spectrum, rather than static mesenchymal traits, drives tumor heterogeneity and metastatic progression of breast cancers MS Brown, B Abdollahi, OM Wilkins, P Chakraborty, NB Ognjenovic, ... bioRxiv, 2021 | 17 | 2021 |
| Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD S Sahoo, D Singh, P Chakraborty, MK Jolly Journal of clinical medicine 9 (3), 870, 2020 | 15 | 2020 |
| Gene expression and chromatin accessibility during progressive EMT and MET linked to dynamic CTCF engagement KS Johnson, S Hussein, S Song, P Chakraborty, MK Jolly, M Toneff, Y Lin, ... bioRxiv, 2020 | 7 | 2020 |
